Average Co-Inventor Count = 4.33
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (13 from 2,076 patents)
2. Ortho-mcneil Pharmaceutical Corp. (13 from 363 patents)
3. Mcneil Ab (3 from 188 patents)
4. Other (2 from 832,680 patents)
5. Millennium Pharmaceuticals Limited (2 from 850 patents)
6. Ortho Pharmaceutical Corporation (1 from 377 patents)
7. Janssen Pharmaceutica (1 from 32 patents)
8. Ortho-mcneil-janssen Pharmaceuticals, Inc. (1 from 1 patent)
34 patents:
1. 9024017 - Octahydro-cyclopentapyrrolyl antagonists of CCR2
2. 8853263 - Co-therapy for the treatment of epilepsy and related disorders
3. 8815939 - Substituted sulfamide derivatives
4. 8445514 - Urotensin II receptor antagonists
5. 8084490 - Sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
6. 8008299 - Urotensin II receptor antagonists
7. 7855203 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
8. 7786135 - Substituted pyrroline kinase inhibitors
9. 7781450 - Substituted pyrroline kinase inhibitors
10. 7759380 - Substituted pyrrolines as kinase inhibitors
11. 7705015 - Substituted pyrroline kinase inhibitors
12. 7608634 - Substituted pyrrolines as kinase inhibitors
13. 7524858 - Substituted pyrroline kinase inhibitors
14. 7329657 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
15. 7312306 - Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators